Qube Research & Technologies (QRT)
BOLD

Qube Research & Technologies (QRT)’s Boundless Bio BOLD Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.2K Sell
17,492
-1,215
-6% -$1.42K ﹤0.01% 3271
2025
Q4 		$22.4K Buy
18,707
+660
+4% +$822 ﹤0.01% 3373
2025
Q3 		$22.2K Sell
18,047
-3,495
-16% -$4.03K ﹤0.01% 3283
2025
Q2 		$21.8K Buy
+21,542
New +$28.6K ﹤0.01% 3250

Other funds holding BOLD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BOLD Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Boundless Bio (BOLD) stake by 6.5% in Q1 2026, selling an estimated $1.42K and leaving 17,492 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3271.

Qube Research & Technologies (QRT) first reported a position in BOLD in Q2 2025 and has held it in 4 quarters since. The position peaked at $22.4K in Q4 2025. 36 funds tracked by Wall St. Rank hold BOLD as of Q1 2026.

  • Qube Research & Technologies (QRT) held 17,492 shares of Boundless Bio worth $19.2K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 1,215 Boundless Bio shares in Q1 2026, an estimated $1.42K.
  • Boundless Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3271 holding.
  • Qube Research & Technologies (QRT) first reported a position in Boundless Bio in Q2 2025 and has held it in 4 quarters since.
  • Qube Research & Technologies (QRT)'s Boundless Bio position peaked at $22.4K in Q4 2025.
  • 36 funds tracked by Wall St. Rank held Boundless Bio as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.